title: [METROPLASTY FOR OBSTETRIC PERITONITIS, ARISING IN THE BACKGROUND SUTURE FAILURE OF THE UTERUS].
abstract: Improving treatment outcomes obstetric peritonitis after cesarean section on the basis of organ-preserving treatment and reasonable intensive care in the postpartum period. Fifteen clinical cases in which on the background of peritonitis were made conserving surgery, which included: excision of necrotic areas on the uterus, uterine cavity curettage, metroplasty. Nasointestinal bowel intubation and drainage of the abdominal cavity. It is discussed tactics of postpartum women with obstetric peritonitis on the background of insolvency seams on the uterus, currently existing criteria for evaluation and treatment of patients data. The necessity of using in the algorithm survey postpartum women with obstetric peritonitis diagnostic criteria SIRS, leukocyte index of intoxication, integrated scales organ dysfunctions. Modern approaches to surgical treatment, the starting antibiotic therapy antibiotics ultra wide spectrum of action, combined with early intensive treatment in an intensive care unit avoids removal of the uterus as a primary focus.
authors.affiliation: West-Kazakhstan State M. Ospanov Medical Universyti, Aktobe, Kazakhstan.
authors.forename: A
authors.initials: A
authors.lastname: Tussupkaliyev
authors.affiliation: West-Kazakhstan State M. Ospanov Medical Universyti, Aktobe, Kazakhstan.
authors.forename: Zh
authors.initials: Z
authors.lastname: Daribay
authors.affiliation: West-Kazakhstan State M. Ospanov Medical Universyti, Aktobe, Kazakhstan.
authors.forename: M
authors.initials: M
authors.lastname: Saduov
authors.affiliation: West-Kazakhstan State M. Ospanov Medical Universyti, Aktobe, Kazakhstan.
authors.forename: M
authors.initials: M
authors.lastname: Dossimbetova
authors.affiliation: West-Kazakhstan State M. Ospanov Medical Universyti, Aktobe, Kazakhstan.
authors.forename: G
authors.initials: G
authors.lastname: Rakhmetullina
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002511:Cephalosporins / Q000627:therapeutic use; D002585:Cesarean Section / Q000009:adverse effects*; D005260:Female; D006801:Humans; D020883:Hysterotomy; D059351:Organ Sparing Treatments; D010126:Ozone / Q000627:therapeutic use; D010538:Peritonitis / Q000209:etiology / Q000601:surgery / Q000628:therapy*; D018805:Sepsis / Q000209:etiology / Q000628:therapy; D013530:Surgical Wound Infection / Q000150:complications*; D018746:Systemic Inflammatory Response Syndrome / Q000209:etiology / Q000628:therapy; D014599:Uterus / Q000601:surgery*; D055815:Young Adult
chemical_list: D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D010126:Ozone